Mission:Cure Blog
The Mission: Cure Blog is written by our team, medical experts, and members of our community in an effort to bring the latest developments and resources to patients and share the pancreatitis experience.
Inspiring CBS Mornings Segment: Two Boys Turn Chess Wins into Hope for Pancreatitis Patient
With heavy hearts, Mission: Cure shares the news of the passing of a visionary leader, dedicated advisor, and generous supporter, Sam Shrauger.
Autoimmune Pancreatitis Webinar
Autoimmune Pancreatitis (AIP) is a rare and complex form of pancreatitis that is often misunderstood, misdiagnosed or overlooked. To help patients and caregivers better understand this condition and offer up-to-date, real-world diagnosis and care information to physicians, Mission: Cure hosted a free educational webinar with leading experts in pancreatic care and autoimmune diseases.
Navigating Steatorrhea in Pancreatitis: Understanding, Management, and Expert Insights
Every day, your pancreas produces around 8 ounces of digestive enzymes to help break down dietary fats. However, when the pancreas is damaged, it can
Stress and Pancreatitis Webinar Q&A
Dr. Amy Serin, a renowned neuropsychologist specializing in stress and stress management, is the founder of the Serin Center and serves as Chief Clinical Advisor
Understanding Pancreatitis and EPI: Diet, Testing & Talking to Your Doctor
Understanding Pancreatitis and EPI: Diet, Testing & Talking to Your Doctor Created with the HealthUnlocked Pancreatitis Community If you’re managing chronic pancreatitis (CP) or exocrine
Stress and Pancreatitis Webinar
Stress and Pancreatitis Connection In this Mission: Cure patient education webinar, internationally recognized neuropsychologist and stress expert Dr. Amy Serin explores how stress impacts people
FDA Approves First-Ever Treatment for IgG4-Related Disease: What This Means for People With Type 1 AIP and Beyond
On April 3, 2025, the FDA approved Uplizna® (inebilizumab-cdon) as the first and only approved treatment for Immunoglobulin G4-related disease (IgG4-RD), the condition behind Type
Amanda’s Pancreatitis Journey: From Diagnosis to TPIAT
My very first attack was when I was 10 years old. I’ll never forget the impact it had on my outlook on the world as
FDA Approves First-Ever Treatment for Familial Chylomicronemia Syndrome (FCS)
Exciting news! The U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA (olezarsen), developed by Ionis, as the first-ever treatment for Familial Chylomicronemia Syndrome (FCS).